SK bioscience to lead Gates Foundation-funded ROTOR project

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Arcturus Therapeutics and Thermo Fisher enter strategic collaboration on ARCT-032 development

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Neurocrine Biosciences initiates crinecerfont Phase 2 study in young children with classic CAH

Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Cumberland Pharmaceuticals sharpens focus on rare disease pipeline with USD100m sale of branded US business to Apotex

Ipsen to acquire Memo Therapeutics to expand rare disease portfolio

Eurobio Scientific completes acquisition of CareDx's transplant lab products business

Aspen Neuroscience completes Cohort 3 and 4 dosing in Parkinson's disease trial

Will Therapeutics announces CQDM-backed research collaboration to improve treatment for anorexia nervosa and other compulsive disorders

Biohaven completes enrolment in opakalim RISE 3 epilepsy study

ADC Therapeutics completes enrolment in Phase 1b ZYNLONTA combination trial

Sanofi reports positive phase 3 results for Nexviazyme in infantile-onset Pompe disease

Zelluna awarded NOK16m research grant for Phase 1 cancer study